Chemical Compound

Prostaglandin E2

CAS Registry Number 363-24-6

Back to search Request a Quote

Primary Record

Prostaglandin E2

In stock: 3,419 g
Purity: 98.8 %
CAS: 363-24-6

Compound Identifiers & Properties

CAS: 363-24-6
PubChem CID: 5280360
SMILES: CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O
Canonical SMILES: CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O

Names & Synonyms

Prostaglandin E2
Dinoprostone
PGE2
Prepidil
Prostin E2
Cervidil
Propess
Minprostin E2
Dinoproston
Minprositin E2
Prostin
Prostarmon E
Dinoprostonum
Dinoprostona
Cerviprost
Glandin
363-24-6
Cerviprime
Prostenone
Enzaprost E
l-Prostaglandin E2
PGE2alpha
primiprost
(15S)-Prostaglandin E2
Prostenon
l-PGE2
Prostaglandin E
Prepidil Gel
Prostin E
PGE2 alpha
Gel, Prepidil
Prostarmon E2
Prostaglandin E2alpha
E2, Prostaglandin
Cervidil (TN)
Prepidil (TN)
Dinoprostone CRS
Prostaglandin,PGE2
(-)-Prostaglandin E2
l-ProstagladinE2
[3H]dinoprostone
alpha, PGE2
Prostaglandin E2 alpha
prosta-glandin e2
Prostaglandin E(2)
Prostin E2 (TN)
Dinoprostone betadex
Prestwick_793
Propess (TN)
Dinoprostonum [INN-Latin]
E2alpha, Prostaglandin
[3H]prostaglandin E2
Dinoprostona [INN-Spanish]
[3H]prostin E2
5-trans-PGE2
alpha, Prostaglandin E2
E2 alpha, Prostaglandin
VIVELLE-DOT
8-isoprostaglandin E2
AC1NQWXW
K7Q1JQR04M
Prostaglandin E2 (GMP)
Prostin (prostaglandin)
CHEMBL548
Dinoprostone Prostaglandin E2
RefChem:56458
UNII-K7Q1JQR04M
Prostaglandin E2.alpha.
[3H]PGE2
Alprostadil EP Impurity G
DINOPROSTONE [INN]
DINOPROSTONE [JAN]
DTXSID4022947
MFCD00077861
D06FEA
C20H32O5
Dinoprostone (JAN/USP/INN)
DINOPROSTONE [USAN]
(+/-)-Prostaglandin E2
U-12062
5,6-cis-Prostaglandin E2
BML1-F07
DTXCID002947
NSC 165560
XEYBRNLFEZDVAW-ARSRFYASSA-N
DINOPROSTONE [VANDF]
PGE-2
SCHEMBL25533
BSPBio_001490
DINOPROSTONE [MART.]
Prostaglandin E2 (Standard)
CHEBI:15551
Dinoprostone [USAN:INN:BAN:JAN]
DINOPROSTONE [USP-RS]
DINOPROSTONE [WHO-DD]
NSC 196514
EINECS 206-656-6
Prostaglandin E2 (Cervidil)?
PROSTAGLANDIN E2 [MI]
GTPL1883
GTPL1916
orb1302168
PGE(2)
(5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
Dinoprostone (Prostaglandin E2)
NSC-165560
NSC-196514
[3H]-PGE2
BDBM35847
Dinoprostone beta-Cyclodextrin Clathrate
DTXSID00859353
G02AD02
U 12062
DINOPROSTONE [ORANGE BOOK]
HMS1361K12
HMS1791K12
HMS1989K12
HMS2089D17
HMS3268J12
HMS3402K12
HMS3413C20
HMS3648F07
HMS3677C20
BMS-279654 & PGE2
DINOPROSTONE [EP MONOGRAPH]
DINOPROSTONE [USP IMPURITY]
(-)-PGE2
AMY30102
EX-A1773
MSK15026
ZINC3830713
Dinoprostone [USAN:BAN:INN:JAN]
DINOPROSTONE [USP MONOGRAPH]
Tox21_111196
Dinoprostone [USAN:USP:INN:BAN:JAN]
EBC-26697
HB3460
LMFA03010003
NCGC00092361-05
NSC165560
NSC196514
ONO-01676
s3003
AKOS015920228
Tox21_111196_1
AC-6098
C20-H32-O5
CCG-208092
CCG-208256
CID5280360
CS-6932
DB00917
FD31827
HY-101952G
HY-101952R
J9.243F
RP17686
Alprostadil EP Impurity G; Dinoprostone
IDI1_033960
SMP2_000056
(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
NCGC00092361-01
NCGC00092361-02
NCGC00092361-03
NCGC00092361-04
NCGC00092361-06
AJ-45765
AN-10387
AS-71847
BC219642
BR-72815
CAS-363-24-6
PGE2-[3,3,4,4-d4]
Prostaglandin E2, 98% - 10MG 10mg
SY057971
U-12,062
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
Dinoprostone 100 microg/mL in Acetonitrile
HY-101952
LS-125823
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate
(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)hept-5-enoic acid
ALPROSTADIL IMPURITY G [EP IMPURITY]
B7005
CS-0626105
NS00009026
P1884
U,062
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
1798-EP2272832A1
1798-EP2277848A1
1798-EP2277858A1
1798-EP2295055A2
1798-EP2298767A1
1798-EP2301922A1
1798-EP2305641A1
1798-EP2305653A1
1798-EP2308510A1
1798-EP2308872A1
1798-EP2311453A1
1798-EP2311808A1
1798-EP2311829A1
1798-EP2314574A1
1798-EP2314587A1
1798-EP2316829A1
7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
C00584
D00079
l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
Prostaglandin E2, >=93% (HPLC), synthetic
5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)-
363P246
A823207
EN300-22411484
Q416554
SR-01000946417
SR-05000001459
(5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(Z)-7-[(1r,2r,3r)-3-Hydroxy-2-[(E,3s)-3-Hydroxyoct-1-Enyl]-5-Oxo-Cyclopentyl]hept-5-Enoic Acid
5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-
SR-01000946417-1
SR-05000001459-1
SR-05000001459-3
SR-05000001459-4
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic
BRD-K26521938-001-04-9
BRD-K26521938-001-07-2
BRD-K26521938-001-09-8
(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
05D31BD5-818B-4A92-8CFC-BEC19926A5B3
11alpha,15alpha-Dihydroxy-9-ketoprosta-5,13-dienoic acid
B1370-286161
Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo-
(5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
2-AMINO-1-BENZO[1,3]DIOXOL-5-YL-ETHANONEHYDROCHLORIDE
5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid
Dinoprostone, European Pharmacopoeia (EP) Reference Standard
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(5Z,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate
11alpha,15alpha-Dihydroxy-9-oxo-5-cis,13-trans-prostadienoic acid
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid; Prostin E2
Dinoprostone, United States Pharmacopeia (USP) Reference Standard
Prosta-5, (5Z,11.alpha.,13E,15S)-11,15-dihydroxy-9-oxo-
Prosta-5, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
Prosta-5, 11,5-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
(5Z,11?,13E,15S)-11,15-Dihydroxy-9-oxo-prosta-5,13-dien-1oic acid
(5Z,11|A,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,11a,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,11I+/-,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,11R,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid
(5Z,13E,15S)-11alpha,15-Dihydroxy-9-oxo-5,13-prostadien-1-oic acid
(5Z,13E,15S)-11alpha,15-Dihydroxy-9-oxo-5,13-prostadiene-1-oic acid
(5Z,13E,15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
(5Z,13E,15S)-9-Oxo-11alpha,15-dihydroxyprosta-5,13-diene-1-oic acid
(Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11alpha,13E,15S)
5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxo-rosta-5,13-dien-1-oic acid
7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentyl]-5-heptenoic acid
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
(5Z,11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
(5Z,8R,13E,15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
[5Z,11alpha,13E,15S,(-)]-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
[5Z,11R,13E,15S,(-)]-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
[5Z,11R,13E,15S,(-)]-11,15-Dihydroxy-9-oxoprosta-5,13-diene-1-oic acid
5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-(8CI)
5-Heptenoic acid, 7-[3alpha-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11.alpha.,13E,15S)-
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11?,13E,15S)-
Prostaglandin E2, gamma-irradiated, powder, BioXtra, suitable for cell culture
(E,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid
(E,Z)-(1R,2R,3R)-7-[3-hydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]-5-oxocyclopentyl]-5-heptenoic acid
(Z)-7-((1R,2R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
(Z)-7-((1R,3R)-3-hydroxy-2-((E,3S)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
206-656-6
22230-04-2
Dinoprostone; (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid; PGE2
P2E